Zoliflodacin
- Generic Name
- Zoliflodacin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C22H22FN5O7
- CAS Number
- 1620458-09-4
- Unique Ingredient Identifier
- FWL2263R77
- Background
Zoliflodacin has been used in trials studying the basic science and treatment of Gonorrhoea.
- Associated Conditions
- -
- Associated Therapies
- -
Zoliflodacin in Uncomplicated Gonorrhoea
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-05-22
- Last Posted Date
- 2024-07-26
- Target Recruit Count
- 1011
- Registration Number
- NCT03959527
- Locations
- 🇺🇸
Public Health - Seattle & King County STD Clinic, Seattle, Washington, United States
🇺🇸Jefferson County Department of Health, Birmingham, Alabama, United States
🇺🇸University of Alabama at Birmingham, Birmingham, Alabama, United States
Study to Investigate Effect of Food and Safety of a New Formulation of Zoliflodacin
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-10-24
- Last Posted Date
- 2018-12-06
- Lead Sponsor
- Drugs for Neglected Diseases
- Target Recruit Count
- 48
- Registration Number
- NCT03718806
- Locations
- 🇺🇸
Quotient Sciences, Miami, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath